Delivery Order SPE2DR25D2104-SPE2DR26F3NEW
Award Date 11/4/25
Potential Completion Date 11/5/25
Potential Value $1.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $5,286.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Teriparatide 560mcg/2.24ml pens on September 8, 2025, with completion scheduled for September 9, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a $2,691.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24ml pen injections, with performance in Conshohocken, Pennsylvania and completion targeted for October 30, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999.999 billion prime vendor agreement...
- The Defense Logistics Agency awarded a delivery order valued at $12,997.91 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560 mcg/2.24 mL pen injections. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of September 30, 2025. The contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through...
- The Defense Logistics Agency awarded a $7,010.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Teriparatide 560mcg/2.24mL pen pharmaceutical products, with an ultimate completion date of November 6, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract will be performed at the vendor's...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Teriparatide 560 MCG/2.24 ML pen injections, valued at $13,783.94. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by August 20, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company serves as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,172.66 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24mL pens on October 28, 2025, with completion scheduled for October 29, 2025. The award utilized firm fixed price pricing with no set-aside designation, indicating the contract was competitively awarded. Performance will be executed from AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24ml pen injections, valued at $22,413.75 under a firm fixed-price contract. The award was made on May 27, 2025, with an ultimate completion date of May 28, 2025, and represents a competitive, non-set-aside procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,458.48 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560 mcg/2.24 mL pen injections. This firm fixed-price, non-set-aside contract was awarded on November 5, 2025, with an ultimate completion date of November 6, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Teriparatide is a hormone-based medication used primarily for osteoporosis treatment,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Teriparatide 560mcg/2.24mL pens valued at $6,554.84 with a firm fixed price structure. The order was competitively awarded without a set-aside designation and is scheduled for completion by September 30, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this delivery from its corporate office location in the same city. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,156.03 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24ml pen injections, with a completion date of May 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the...